Johnson & Johnson's Fiscal Year is From January To December.
The item "Price-To-Tangible-Book-Ratio" stands at 13.88 as of 09/30/2025, the highest value since 06/30/2023.
As of the end of Johnson & Johnson's third quarter, the item "Price To Tangible Book Ratio" stands at 13.88. This represents an increase of 10.50 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 14.73 percent compared to the value the year prior.
The 1 year change in percent is 14.73.
The 3 year change in percent is 31.96.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Price To Tangible Book Ratio | 905,699,262,464.00 |
![]() | AbbVie Inc - Price To Tangible Book Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Price To Tangible Book Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Price To Tangible Book Ratio | 280,205,508,085.11 |
![]() | Novartis AG - Price To Tangible Book Ratio | 255,096,620,580.91 |